Leila Rastegar Zegna is a prominent entrepreneur turned venture capitalist who is making waves in the industry for her novel approach to investing. As a founding general partner at Kindred Capital VC, she is building a more collaborative and generous form of venture capital, turning every founder into a partner in the fund. She has a remarkable track record of working with ambitious founders who are making a positive impact in their respective domains.

Leila Rastegar Zegna has an impressive academic background, having studied Mathematics and Philosophy cum laude with distinction at Yale University, and completing an MBA at Harvard Business School in 2011. She has also held several leadership positions at various organizations, including board member at Eleven Therapeutics, board director at Gaia, and senior advisory board member at Entrepreneur First.

Apart from her professional work, Leila is also deeply committed to rare disease research and progress. She is a board director at the Kabuki Syndrome Foundation and has established the Roya Kabuki Program at Boston Children's Hospital. A voracious learner, Leila is passionate about helping passionate people, making her a sought-after mentor and advisor in the startup community.

Overall, Leila Rastegar Zegna is a force to be reckoned with in the world of venture capital, entrepreneurship, and rare disease research, and her innovative approach and dedication to her work make her an invaluable asset to the industry.

---